Pregabalin drug interaction studies: Lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy

Epilepsia

Volumn 46, Issue 9, 2005, Pages 1407-1413

  Brodie, Martin J ^b   Wilson, Elaine A ^b   Wesche, David L ^a   Alvey, Christine W ^a   Randinitis, Edward J ^a   Posvar, Edward L ^a,b,e   Hounslow, Neil J ^a   Bron, Nicola J ^a   Gibson, G L ^c   Bockbrader, Howard N ^a,d  

^a PFIZER INC   (United States)

^b WESTERN INFIRMARY   (United Kingdom)

^c Clinical Study Centers LLC   (United States)

^d Amgen Inc ^*  (United States)

^e AMGEN INC   (United States)

Author keywords

Drug drug interaction; Lyrica; Pregabalin

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE; LAMOTRIGINE; PHENYTOIN; PREGABALIN; VALPROIC ACID; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; TRIAZINE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; ATAXIA; CONVULSION; COORDINATION DISORDER; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; HEART INFARCTION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; NEUROPATHIC PAIN; NYSTAGMUS; PRIORITY JOURNAL; SEIZURE; SOMNOLENCE; STEADY STATE; VERTIGO; XEROSTOMIA; ADOLESCENT; BLOOD; COMPARATIVE STUDY; DRUG COMBINATION; DRUG INTERACTION; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; TRIAZINES; VALPROIC ACID;

EID: 26944476349     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.19204.x     Document Type: Article

References (33)

1. Miller R Frame B Corrigan BW, et al. Mixed effects modeling of pregabalin response in patients with refractory partial seizures [Abstract]. Clin Pharmacol Ther 2001 69 : 78.
2. Ramsay RE Kugler AR Anhut H, et al. Pregabalin adjunctive therapy in patients with partial seizures [Abstract]. Epilepsia 2001 42 ( suppl 7 211.
3. Robbins JL Kugler AR Anhut H, et al. Pregabalin shows anticonvulsant activity onset by second day [Abstract]. Epilepsia 2001 42 ( suppl 7 211 2.
4. Minecan DN Passaro EA Murugaiyan P, et al. Long-term efficacy and safety of pregabalin for the treatment of partial onset seizures [Abstract]. Epilepsia 2001 42 ( suppl 7 184.
5. Arroyo S Anhut H Kugler AR, et al. Pregabalin: add-on treatment: a double-blind, placebo-controlled multicenter study in patients with partial seizures. Epilepsia 2004 45 : 20 7.
6. Beydoun A Uthman BM Kugler AR, et al. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005 64 : 475 80.
7. French JA Kugler AR Robbins JL, et al. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003 60 : 1631 7.
8. Uthman BM Lee CM Spiegel K. Long-term seizure freedom in patients with partial seizures treated with add-on pregabalin: an analysis of four, long-term, open-label trials. Epilepsia 2004 45 ( suppl 7 1 393.
9. Lauria-Horner BA Pohl RB. Pregabalin: a new anxiolytic. Expert Opin Invest Drugs 2003 12 : 663 72.
10. Dooley DJ Donovan CM Meder WP, et al. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked. Synapse 2002 45 ( suppl 1 171 90.
11. Gee NS Brown JP Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the α2δ subunit of a calcium channel. J Biol Chem 1996 271 : 5768 76.
12. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002 42 : 229 36.
13. +-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000 280 : 107 10.
14. 3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000 295 : 1086 93.
15. 3H]glutamate from rat caudal trigeminal nucleus slices. Pain. 2001 93 : 191 6.
16. Taylor CP. The biology and pharmacology of calcium channel a2-d proteins. CNS Drug Rev 2004 10 : 159 64.
17. Bialer M Johannessen SI Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res 1999 34 : 1 41.
18. Welty D Wang Y Busch JA, et al. Pharmacokinetics (PK) and pharmacodynamics (PD) of CI-1008 (pregabalin) and gabapentin in rats with maximal electroshock [Abstract]. Epilepsia 1997 38 ( suppl 8 35. abstract 1.110.
19. Corrigan BW Pool WF Posvar EL, et al. Metabolic disposition of pregabalin in healthy volunteers [Abstract]. Clin Pharmacol Ther 2001 69 : 18.
20. Bockbrader HN Burger PJ Corrigan BW, et al. Population pharmacokinetic (PK) analysis of pregabalin (PGB) in adult patients with refractory partial seizures [Abstract]. Epilepsia 2001 42 ( suppl 7 84.
21. Randinitis EJ Posvar EL Alvey CW, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003 43 : 277 83.
22. Ketter TA Flockhart DA Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995 15 : 387 98.
23. Besag FMC McShane T Neville B, et al. Factors associated with serious skin reactions in children aged 12 years and undertaking lamotrigine. Dev Med Child Neurol 1999 41 : 67 9.
24. Guberman AH Besag FMC Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999 40 : 985 91.
25. Messenheimer J Mullens EL Giorgi L, et al. Safety review of adult clinical trial experience with lamotrigine. Drug Saf 1998 18 : 281 96.
26. Data on file. Parke-Davis Pharmaceutical Research Protocol 2000 1008 3.
27. Data on file. Parke-Davis Pharmaceutical Research Protocol 2000 1008 128-0.
28. Windsor BL Radulovic LL. Measurement of a new anticonvulsant, (S)-3-(aminomethy1)-5-methylhexanoic acid, in plasma and milk by high-performance liquid chromatography. J Chromat (Biomed Appl) 1995 674 : 143.
29. Busch JA Strand JA Posvar EL, et al. Pregabalin (CI-1008) multiple-dose pharmacokinetics and safety/tolerance in healthy volunteers. Pharm Sci 1999 1 ( suppl 4 2033.
30. Data on file. Parke-Davis Pharmaceutical Research Protocol 2000 1008 2.
31. Bockbrader HN Burger PJ Kugler AR, et al. Population pharmacokinetic (PK) analyses of commonly prescribed antiepileptic drug (AEDs) coadministered with pregabalin (PGB) in adult patients with refractory partial seizures [Abstract]. Epilepsia 2001 42 ( suppl 7 84.
32. Kwan P Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001 42 : 1255 60.
33. Reilly JG Ayis SA Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000 355 : 1048 52.